BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6775862)

  • 1. A micromethod for clotting tests and coagulation factor assays.
    Exner T; Margolis J; Rickard KA
    Clin Lab Haematol; 1980; 2(3):227-30. PubMed ID: 6775862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay.
    Matsumoto T; Shima M; Takeyama M; Yoshida K; Tanaka I; Sakurai Y; Giles AR; Yoshioka A
    J Thromb Haemost; 2006 Feb; 4(2):377-84. PubMed ID: 16420569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARTIAL THROMBOPLASTIN TIME TEST WITH KAOLIN. NORMAL RANGE AND MODIFICATIONS FOR THE DIAGNOSIS OF HAEMOPHILIA AND CHRISTMAS DISEASE.
    MATCHETT MO; INGRAM GI
    J Clin Pathol; 1965 Jul; 18(4):465-71. PubMed ID: 14318702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An unified method of one-stage quantitative analysis of factors VIII and IX. I. (Results of the studies of the working group of the All-Union Problem-Solving Commission on "Pathology of hemostasis")].
    Barkagan ZS
    Gematol Transfuziol; 1991 Apr; 36(4):33-5. PubMed ID: 1906034
    [No Abstract]   [Full Text] [Related]  

  • 5. Partial thromboplastin time test with kaolin: diagnosis of haemophilia and Christmas disease without natural reference plasmas.
    Knights SF; Ingram GI
    J Clin Pathol; 1967 Jul; 20(4):616-9. PubMed ID: 5602576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal factor VIII and IX levels in early pregnancy and their significance in prenatal diagnosis.
    Fortune WA; Cox JR
    Acta Haematol; 1973; 49(5):314-7. PubMed ID: 4198913
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum transfusion in hemophiliacs.
    Kimura A
    Tohoku J Exp Med; 1973 Oct; 111(2):125-36. PubMed ID: 4784393
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
    Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ
    Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requiem to prenatal diagnosis of haemophilia A and B using coagulation activity and antigen based assays: not yet!
    Shetty S; Ghosh K; Anbhavne S; Mohanty D
    Eur J Haematol; 2003 Apr; 70(4):253-4. PubMed ID: 12656753
    [No Abstract]   [Full Text] [Related]  

  • 10. Standardization of FVIII & FIX assays.
    Barrowcliffe TW
    Haemophilia; 2003 Jul; 9(4):397-402. PubMed ID: 12828675
    [No Abstract]   [Full Text] [Related]  

  • 11. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO).
    Hay CR; Baglin TP; Collins PW; Hill FG; Keeling DM
    Br J Haematol; 2000 Oct; 111(1):78-90. PubMed ID: 11091185
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possibilities of detection of haemophilia carriers (author's transl)].
    Marbet GA; Marbet B; Duckert F
    Ther Umsch; 1979 Apr; 36(4):334-40. PubMed ID: 451952
    [No Abstract]   [Full Text] [Related]  

  • 13. The diagnosis of mild haemophilia by the partial thromboplastin time test. WFH/ICTH study of the Manchester method.
    O'Brien PF; North WR; Ingram GI
    Thromb Haemost; 1981 Apr; 45(2):162-8. PubMed ID: 6789495
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of partial thromboplastin time. 3].
    Yatani N; Shimoda T; Kanuma K; Genba A; Tzsukada H
    Rinsho Byori; 1971 Aug; 19():Suppl:247. PubMed ID: 5167945
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the demonstration of a factor VIII or IX deficiency by means of partial thromboplastin time].
    Lutze G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(6):933-7. PubMed ID: 64436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple screening tests for the diagnosis of isolated clotting factor defects. With special reference to 'contact factor' defects.
    Ingram GI; Knights SF; Arocha-Piñango CL; Shepperd JP; Pérez-Requejo JL; Mills DK
    J Clin Pathol; 1975 Jul; 28(7):524-30. PubMed ID: 1080159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1.
    Girolami A; Dal Bo Zanon R; Procidano M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):863-71. PubMed ID: 6176512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thromboplastin generation test and possible errors in its reproducibility].
    Tarasova LN
    Lab Delo; 1980; (11):669-71. PubMed ID: 6160299
    [No Abstract]   [Full Text] [Related]  

  • 19. [Method of determining factor IX activity].
    Taran LD; Radionova MN
    Ukr Biokhim Zh (1978); 1996; 68(5):98-102. PubMed ID: 9229862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of source of phospholipids for APTT-based factor IX assays and potential consequences for the diagnosis of mild haemophilia B.
    Pouplard C; Trossaert M; LE Querrec A; Delahousse B; Giraudeau B; Gruel Y
    Haemophilia; 2009 Jan; 15(1):365-8. PubMed ID: 18811593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.